Sialidosis are autosomal recessive inherited disorders caused by a mutation on the NEU1 gene. In type 1 sialidosis, a "cherry-red spot" can be observed in fundoscopic examinations. In this study, a woman aged 37 years without "cherry-red spot" on ophthalmologic examination is reported to draw attention to a new phenotypic variation. Although an ophthalmologic examination was normal, for patients with consanguineous parents with progressive ataxia, drug-resistant epilepsy and myoclonus must be investigated for progressive myoclonic epilepsy and genetic analysis for sialidosis must be performed. The diagnosis is also crucial for genetic consultancy of the family.
Introduction
Sialidosis, which is among the rare causes of progressive myoclonic epilepsy (PME), involves a deficiency in the activity of lysosomal neuroaminidase 1 (NEU1) enzyme. It is an autosomal recessive lysosomal storage disease caused by a mutation in the NEU1 gene. It is divided into two groups depending on the onset of disease and clinical findings. Type 1 sialidosis has a relatively late onset. Its course is relatively benign, dysmorphic features are absent, ataxia, myoclonus, and seizures are present, and typically a "cherry-red spot" is seen in an examination of the fundus (1, 2) .
In type 2 disease with infantile onset, dysmorphic features, organomegaly, and severe mental retardation are seen. To date, 42 mutations that cause sialidosis have been reported on the NEU1 gene, which is located on the 6p21.6 locus of the 6 th chromosome, and these mutations cause genetic heterogeneity (3, 4) .
We present a patient who had slowly progressive ataxia comorbid with refractory epilepsy and myoclonus. Her parents were 3 rd degree relatives. Although she had been diagnosed as having PME for years, a true etiologic diagnosis could not be made due to the absence of a "cherry-red spot"; however, a genetic evaluation revealed NEU1 mutation. We present this case to highlight the phenotypic variability in the clinical presentation of sialidoses.
Case Report
A woman aged 37 years from Siverek, Şanlıurfa, presented with symptoms of bilateral whole body tremor, jerks, and imbalance, which was prominent in the left hand, especially in the mornings. The symptoms first started when she was seventeen and generalized tonic-clonic seizures (GTCS) began in the same year. Her convulsions were triggered during periods of excitation and tremor also increased. Despite treatment with valproic acid, clonazepam, pyrimidone, and piracetam, the seizures repeated at least once a month. Speech disorder and forgetfulness joined these symptoms after 3-4 years. There was nothing significant in her medical history except two falls without loss of consciousness. Her family history revealed that her parents were 3 rd degree relatives and her cousin, who was aged 6 years, a history of GTCS without accompanying tremor or jerks that started after a fall. Her neurologic examination revealed dysarthric speech, ataxia, and positive and negative myoclonus in extremities, which were generalized, synchronized, and augmented with action. She stood up with bilateral support, myoclonus increased when she stepped forward, and after a few steps she tended to fall due to negative myoclonus. Her mental status was within normal limits and she succeeded in university entrance exams. Anamnesis and physical examination findings suggested PME and etiologic assessments were performed. The differential diagnosis included UnverrichtLundborg disease, Lafora disease, myoclonic epilepsy with raggedred fibers, sialidosis, neuronal ceroid lipofuscinosis and celiac disease. A skin biopsy, which was evaluated twice, muscle biopsy, ophthalmic examination, duodenal biopsy, detailed biochemical analyses, and lactate value were normal and antigliadin antibodies were negative. Electroencephalograph (EEG) evaluation revealed mild and general disorder in organization, prominent in the anterior half of the hemispheres, and hypersynchronization in the vertex. Neuropsychologic evaluation revealed impairments in executive function (frontal signs) such as increase in interference time, deficiency in category formation and changing, perseverations and decrease in mental flexibility. Cranial magnetic resonance imaging (MRI) showed cerebral and cerebellar atrophy. Back-averaging was used for the neurophysiologic evaluation and approximately 20-ms discharges priming myocloni were observed in the contralateral brain hemisphere triggered by potentials recorded from superficial electrodes that were located on the left forearm extensor muscles. Median somatosensory-evoked potential (SEP) evaluation revealed bilateral giant cortical responses (>20 μV). With right median nerve stimulation, a moderate latency C reflex was recorded from the right thenar muscles. With doublestimulus transcranial magnetic stimulation no inhibitory response (which is expected under normal conditions) was seen after the 2 nd stimulus at 100-ms interstimulus intervals. Nervous conduction, visual evoked potentials, and tibial SEP evaluations were within normal limits. The electrophysiologic findings of the patient are summarized in Figure 1 . Although photosensitivity and typical generalized epileptiform activity were not observed, UnverrichtLundborg disease was considered depending on the clinical features but genetic evaluations demonstrated a normal-sized cystathionine B gene promoter region, and an increase in dodecamer repeat numbers or point mutations were not detected. SCARB2 gene was evaluated for autosomal recessive cerebellar ataxias because of the severe body ataxia and the result was negative. Laforin and Malin genes were evaluated despite absence of Lafora bodies in the skin biopsy, relatively mild course, and lack of prominent mental findings; no mutation was detected. Although the ophthalmologic evaluation was within normal limits, a NEU1 mutation leading to c.914G>A and c625delG protein variation was detected in the genetic evaluation, which was performed in Finland (5) . A change in c625delG was previously defined in the same codon and was reported as pathogenic (6) . However, the c.914G>A that we detected in the same codon has not been previously reported to be pathogenic (7) . Repeated ophthalmologic evaluation confirmed absence of "cherry-red spot". The patient, who had been followed up in our clinic for 14 years, was restricted to a wheelchair because of severe ataxia. GTCS declined in the last year after zonisamide 200 mg/day was added to her treatment, which previously comprised valproic acid 1500 mg/day, levetiracetam 2000 mg/day, and clonazepam 4 mg/day. Discussion PME is a rare group of genetic, symptomatic, and generalized epilepsies. Myoclonic seizures, GTCS, progressive neurologic findings, ataxia, and dementia are seen in patients with PME. The differential diagnosis is performed depending on age of onset, accompanying symptoms, cerebellar signs, and presence of dementia but a definite diagnosis is difficult due to variability of etiologies and phenotypes (8) . Sialidoses are very rare diseases that are listed in PME etiologies, and diagnosis is usually made by genetic confirmation after observation of elevated urinary sialic acid or by demonstration of neuraminidase enzyme defect in fibroblast cultures (6, 9) . They are usually missed in patients with PME who lack typical clinical findings and "cherry-red spot". Nevertheless, we detected a mutation in the NEU1 gene in our patient.
Myoclonus in these patients limits activities of daily life after progression of disease, and may cause injuries due to falls (8) . Although hypothesis of gamma-aminobutyric acid dysfunction in inhibitory interneurons was proposed, mechanism of action myoclonus in PME forms has not yet been clearly understood. A study by Canafoglia et al. (9) showed more cortical irregularity in patients with sialidosis compared with patients with UnverrichtLundborg disease. Presence of giant SEP waves, cortical potentials priming myocloni seen with back-averaging, C reflex, and decreased cortical inhibition with double-stimuli transcranial magnetic stimulation evaluation suggested these myocloni to be cortically originated. Moreover, although cranial MRI may be normal at an early period, and repeated MRIs show diffuse cortical atrophy, just like in our patient (10) . PMEs may clinically resemble juvenile myoclonic epilepsy and with EEG findings, but treatment refractoriness, progressive neurologic and EEG findings lead to PME diagnosis. A basic activity consisting of fast rhythms may be seen in EEG, but slowing is more prominent in patients with dementia (8). Our patient also had mild slowing in EEG during her follow up for 14 years and neuropsychologic findings that supported mild dementia in recent years.
Treatment generally aims to stop seizures and myoclonus. Antiepileptic medications used to control myocloni are combinations of valproic acid, benzodiazepines, phenobarbital, piracetam, zonisamide, and levetiracetam. The effects of these drugs on myoclonus increase during the first 12 months and then stay steady. Additionally, drugs that increase myoclonus such as vigabatrine, carbamazepine, phenytoin, and gabapentin should be avoided. In the future, new management strategies such as gene treatment and enzyme replacement therapies are promising possible treatments (11, 12) . Our patient's seizures were also controlled during the last year after with the addition of zonisamide to her treatment regime. Fundoscopic examination is important in patients who develop ataxia in the early ages. A "cherry-red spot" or perifoveal white patch can be detected in the fundoscopic examination. Although this phenomenon is a classic finding for sialidosis, it may also be seen in GM1 gangliosidosis, hexoseaminidase defect, and Nieman-Pick and Gaucher's disease (13) . In addition, a few cases were reported in which a "cherryred spot" was not detected, despite the presence of a mutation in the NEU1 gene (6, 9) . We also could not detect "cherry-red spot" despite the presence of a NEU1 mutation; this documents the presence of a new phenotype in our country.
Conclusion
In conclusion, all evaluations for PMEs should be made in patients with progressive ataxia, refractory epilepsy, and myoclonus. A genetic evaluation should be performed in patients with sialidosis whose clinical and electrophysiologic findings suggest PME, despite normal fundoscopic evaluation. Diagnosis is important for this rare form of hereditary sialidosis for which gene treatments may be possible in the future.
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